Survival Study of the Genutech® Total Knee Arthroplasty
1 other identifier
observational
500
1 country
1
Brief Summary
Prospective cohort sudy of patients undergoing a Genutech® total knee arthroplasty
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedFirst Submitted
Initial submission to the registry
March 11, 2025
CompletedFirst Posted
Study publicly available on registry
March 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2032
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2033
March 28, 2025
March 1, 2025
11 years
March 11, 2025
March 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients without revision surgery
the main goal is to determine the implant survival, that is, having no revision during follow-up. The number of patients requiring revision will be compared to the total of patients included in the study.
5 and 10 years
Secondary Outcomes (3)
Oxford Knee Score
one, 5 and 10 years
SF12 questionnaire
1, 5 and 10 years postoperatively
WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) questionaire
One, 5 and 10 years
Eligibility Criteria
Patients referred to the investigators' Institution by Primary Care centres to receive Orthopaedic care
You may qualify if:
- Patients older than 18 years with knee osteoarthritis that had not responded to conservative treatment
- capable of providing informed consent
- patients who receive a Genutech® total knee prosthesis at the investigators' Institution.
You may not qualify if:
- having received a prior total knee arthroplasty in the same joint
- inability to provide informed consent
- not willing to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Sant Rafael
Barcelona, Barcelona, 08035, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 11, 2025
First Posted
March 28, 2025
Study Start
January 1, 2021
Primary Completion (Estimated)
January 1, 2032
Study Completion (Estimated)
January 1, 2033
Last Updated
March 28, 2025
Record last verified: 2025-03